These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8494021)

  • 1. Sodium-lithium countertransport activity in red blood cells of patients with IgA nephropathy.
    Boero R; Fabbri A; Degli Esposti E; Guarena C; Forneris G; Lucatello A; Sturani A; Quarello F; Fusaroli M; Piccoli G
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):61-5. PubMed ID: 8494021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients.
    Boero R; Degli Esposti E; Fabbri A; Guarena C; Forneris G; Quarello F; Fusaroli M; Piccoli G
    Kidney Int; 1991 Dec; 40(6):1118-22. PubMed ID: 1762312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of red cell sodium-lithium countertransport in hyperlipidemias.
    Corrocher R; Steinmayr M; Ruzzenente O; Brugnara C; Bertinato L; Mazzi M; Furri C; Bonfanti F; De Sandre G
    Life Sci; 1985 Feb; 36(7):649-55. PubMed ID: 3968981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of erythrocyte sodium/lithium countertransport activity in families of patients with immunoglobulin A nephropathy.
    Fabbri A; Boero R; Degli Esposti E; Guarena C; Lucatello A; Sturani A; Piccoli G; Fusaroli M
    Clin Sci (Lond); 1992 Aug; 83(2):241-5. PubMed ID: 1327641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Red-cell sodium-lithium countertransport in patients with IgA nephrology and renal hypertension].
    Chen YD; Zheng FL; Wen LR
    Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):214-7, 254. PubMed ID: 7922761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man.
    Petrov VV; Britov AN; Levitsky DO; Minchenko BI; Konstantinov EN; Svidersky VD; Novikov ID; Grishenkov EA; Lijnen PJ
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):661-6. PubMed ID: 7746028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritability of erythrocyte Na+-Li+ countertransport in relation to essential hypertension.
    Kagamimori S; Takata M; Naruse Y; Watanabe M; Miyamoto N; Okada A
    Clin Exp Hypertens A; 1984; 6(5):951-60. PubMed ID: 6329557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte sodium-lithium countertransport in non-modulating offspring and essential hypertensive individuals: response to enalapril.
    Sánchez RA; Giménez MI; Migliorini M; Giannone C; Ramírez AJ; Weder AB
    Hypertension; 1997 Jul; 30(1 Pt 1):99-105. PubMed ID: 9231828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte sodium/lithium countertransport and renal lithium clearance in a random sample of untreated middle-aged men.
    Strazzullo P; Cappuccio FP; Trevisan M; Iacoviello L; Iacone R; Jossa F; Giorgione N; Farinaro E; Mancini M
    Clin Sci (Lond); 1989 Sep; 77(3):337-42. PubMed ID: 2805596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between altered Na+--K+ cotransport and Na+--Li+ countertransport in the erythrocytes of 'essential' hypertensive patients.
    Cusi D; Barlassina C; Ferrandi M; Palazzi P; Celega E; Bianchi G
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():33s-36s. PubMed ID: 7318333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
    Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
    Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixture analysis of erythrocyte lithium-sodium countertransport and blood pressure.
    Weder AB; Schork NJ
    Hypertension; 1989 Feb; 13(2):145-50. PubMed ID: 2914736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte sodium-lithium countertransport in Chinese: its relationship to family history of hypertension.
    Lau YT; Wu D; Liang HC; Chen MC
    Clin Exp Hypertens A; 1992; 14(3):489-503. PubMed ID: 1318176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral resistance and red cell Li-Na countertransport in borderline hypertensives.
    Fujita T; Noda H; Ando K; Sato Y
    Life Sci; 1983 Apr; 32(14):1621-7. PubMed ID: 6835006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents.
    Walker JD; Tariq T; Viberti G
    BMJ; 1990 Sep; 301(6753):635-8. PubMed ID: 2224216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of physical work capacity, blood pressure and other hypertension risk factors with the rate of erythrocyte Na/Li countertransport].
    Kocharov AM; Britov AN; Kobal' AM; Grishenkov EA
    Kardiologiia; 1992 Jun; 32(6):30-1. PubMed ID: 1405288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-lithium countertransport and blood pressure in healthy blood donors.
    Turner ST; Johnson M; Boerwinkle E; Richelson E; Taswell HF; Sing CF
    Hypertension; 1985; 7(6 Pt 1):955-62. PubMed ID: 4077225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial aggregation of cation transport abnormalities and essential hypertension.
    Cusi D; Barlassina C; Ferrandi M; Lupi P; Ferrari P; Bianchi G
    Clin Exp Hypertens (1978); 1981; 3(4):871-84. PubMed ID: 7297328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal sodium-lithium countertransport kinetics in immunoglobulin A nephropathy patients and the families: association with hypertension.
    Ho KL; Rutherford PA; Thomas TH; Wilkinson R
    Am J Kidney Dis; 1996 Mar; 27(3):334-40. PubMed ID: 8604701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-lithium countertransport in erythrocytes of children and adolescents with hypertension.
    Norling LL; Goldring D; Hernandez A; Robson AM; Landt M
    Dev Pharmacol Ther; 1986; 9(4):231-40. PubMed ID: 3757730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.